The New Torrent
The 'pharmaceutical to power' group has kickstarted a makeover plan with focus on renewable and diversification into health.
usfda
November 2024
June 2024
March 2024
November 2023
October 2023
September 2023
July 2023
April 2023
Sun Pharma shares drop 2% on USFDA warning letter
The USFDA has issued a letter for violations of Current Good Manufacturing Practice (cGMP) regulations at Sun Pharma’s Dadra facility.
Torrent Pharma shares hit 52-week high; here's why
The USFDA conducted the pre-approval inspection at the company’s oral-oncology manufacturing facility situated in Bileshwarpura, Gujarat from December 5 to December 11 last year.
Aurobindo Pharma shares rise 2% on USFDA approval for asthma drug
Aurobindo Pharma has received approval from USFDA to produce and trade Budesonide Inhalation Suspension
Cipla stock tanks 8% after USFDA warning over issues at MP unit
Warning letter stresses data integrity issues at company embedded with product complaints and microbial contamination
Biocon shares drop 6% after USFDA inspection of Malaysian unit
The OAI status may cause delay or withholding of pending product approvals or supplements from the facility, Biocon says
Strides Pharma surges 10% on USFDA's approval for Icosapent Ethyl capsules
Strides Pharma Global Pte Limited, Singapore, which is a wholly-owned subsidiary of Strides Pharma, has received approval for Icosapent Ethyl Capsules 0.5 gram and 1 gram, from the USFDA.
Zydus Lifesciences gets USFDA nod for cancer drug; stock hits 52-week high
The share price of the drugmaker has risen 92% in the last one year from its 52-week low of ₹340.60 touched on July 27, 2022.
Dr. Reddy's shares hit 52-week high as USFDA completes inspection of API plant
The pharma major received “zero observations” post the USFDA pre-approval inspection (PAI) and a routine GMP inspection at the Andhra Pradesh facility
Zydus Lifesciences gets USFDA nod for osteoporosis drug; stock hits 52-week high
The USFDA has allowed Zydus to manufacture and market Estradiol Transdermal System USP in the U.S; the drug will be produced at the group’s facility in Moraiya, Ahmedabad.
